Skip to main content
. 2017 Sep 27;12(9):e0185217. doi: 10.1371/journal.pone.0185217

Fig 2. Immunostaining of anti-survivin.

Fig 2

Examples of survivin immunostaining in a non-recurrent meningioma (A) and a recurrent meningioma (B) (magnitude 400x). The expression of survivin was significantly higher in recurrent meningiomas compared with non-recurrent meningiomas. The bar on the figures represent 100 μm.